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Plasminogen activator inhibitor type 2 (PAI-2) is an
unusual serine proteinase inhibitor in that it is largely
retained within the cell and is found in high concentra-
tions in the upper viable layers of human epidermis.
Studies using transfected cell lines that express high levels
of PAI-2 have suggested that this inhibitor may confer
protection against programmed cell death. To test the
hypothesis that PAI-2 may protect epithelial cells in vivo
from premature programmed cell death, we determined
expression patterns of PAI-2 in murine hair and nail.
These epidermal derivatives are comprised of numerous
epithelial cell types with distinct differentiation path-
ways. Furthermore, the cyclic nature of the follicular
epithelium makes it ideal for studying sequential
stages of cell differentiation and death. PAI-2 mRNA and
Plasminogen activator inhibitor 2 (PAI-2) is a serineproteinase inhibitor originally purified from humanplacenta (Bachmann, 1995; Kruithof et al, 1995). At leastunder normal circumstances, the in vivo distribution ofPAI-2 appears rather limited, with the highest levels noted
in skin keratinocytes (Kawata et al, 1996). PAI-2 is also found in large
amounts in monocytes/macrophages, but in contrast to many serine
proteinase inhibitors, it is not detectable in plasma, except during the
latter stages of pregnancy (Kruithof et al, 1995). Although kinetic data
indicate that PAI-2 is an effective inhibitor of both urokinase type
plasminogen activators (uPA) and tissue type plasminogen activators, its
physiologic role remains undefined (Andreasen et al, 1990). Plasminogen
activators catalyze the conversion of plasminogen to its active form,
plasmin, and thereby are responsible for the cleavage of fibrin and
other extracellular matrix molecules relevant to vascular patency and
tissue remodeling (Collen and Lijne, 1991; Conese and Blasi, 1995;
Andreasen et al, 1997). As these proteolytic activities are extracellular,
any candidate inhibitor for uPA and/or tissue type plasminogen
activator would likewise be expected to have an extracellular distribu-
tion. Surprisingly, PAI-2 is in many cases not secreted but is rather
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protein were detected in the differentiating cells of the
outer root sheath and medulla of the follicle during
the anagen phase of the hair growth cycle. PAI-2 was
also detected in the permanent portion of the catagen
follicle. In the telogen phase of the hair growth cycle,
PAI-2 was limited to the postmitotic cells of the outer
root sheath directly abutting the club hair. In the nail,
PAI-2 was detected in the differentiating cells of the
matrix and nail bed. This consistent, selective distribu-
tion of PAI-2 in the postmitotic, maturing cells prior to
terminal keratinization and death suggests that (i) PAI-2
may be considered as a differentiation marker for many
epithelial cell types, and (ii) PAI-2 is appropriately posi-
tioned to protect epithelial cells from premature demise.
Key words: epithelia/keratinization/programmed cell death. J
Invest Dermatol 110:917–922, 1998
concentrated intracellularly (Medcalf et al, 1988; Belin et al, 1989),
leading to speculation that it has roles other than inhibition of
plasminogen activators.
Hints to a possible intracellular function for PAI-2 have come from
examination of cell lines transfected with PAI-2 cDNA (Kumar and
Baglioni, 1991; Dickinson et al, 1995). Such cell lines, which produce
large amounts of active PAI-2 and retain most of it in the cytoplasm,
are resistant to programmed cell death induced by several but not all
stimuli. These data have led to the hypothesis that PAI-2 may function
intracellularly to protect cells from programmed cell death.
PAI-2 mRNA and protein are present in the more differentiated
epithelial cells of human epidermis and hair follicle (Hibino et al,
1988; Lyons-Giordano et al, 1994). Furthermore, studies with human
keratinocytes in culture have shown that PAI-2 has characteristics of a
differentiation antigen, at least some of which is incorporated into the
squame-like cells (Jensen et al, 1995; Robinson et al, 1997). Based on
these data and the transfected cell line experiments described above,
we have hypothesized that PAI-2 may protect the differentiating
keratinocyte from undergoing the final stages of terminal differentiation
and death. A premature demise, prior to the time when the keratinocyte
has elaborated all of the differentiation products necessary to generate
a fully developed stratum corneum or hair shaft, would obviously have
very deleterious effects on the organism.
The hair follicle is an ideal model with which to test further our
hypothesis that PAI-2 may play a role in terminal differentiation,
because the cyclic nature of this epidermal derivative provides numerous
opportunities to study events involved in epithelial maturation and
terminal differentiation (Lavker et al, 1998). Hair follicles undergo
cycles of growth (anagen), involution (catagen), and rest (telogen),
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which in juvenile mice can be easily studied because they are highly
synchronized and well timed (Wilson et al, 1994). During anagen, the
matrix keratinocytes in the bulb region proliferate rapidly (Van Scott
et al, 1963; Weinstein and Mooney, 1980); however, upon becoming
postmitotic they differentiate into the inner root sheath, as well as the
cuticle, cortex, and medulla of the hair shaft (Reynolds and Jahoda,
1993). At the end of anagen, matrix keratinocytes abruptly cease
proliferating and enter a phase of rapid programmed cell death, so that
the lower follicle involutes and regresses (Chase, 1954; Dry, 1962;
Seiberg et al, 1995). This stage is known as catagen. At the end of
catagen, the follicle enters a period of rest (telogen), characterized by
extremely low proliferative rates and no further growth of the hair
shaft (Wilson et al, 1994). The telogen hair has a club-shaped proximal
end within the hair follicle, which in mice and rats is not lost until a
new hair is fully formed from a subsequent anagen (Chase, 1954; Dry,
1962). Retention of the telogen hair is essential because a dense, intact
coat of hair functions in a thermoregulatory capacity and as a first
line of defence from abrasions, properties vital for the survival of
these animals.
In this study we have determined the protein and mRNA expression
patterns of PAI-2 in the various epithelial cells that constitute the
murine follicular epithelia during the three phases of the hair growth
cycle. We have also studied the distribution of PAI-2 in the murine
nail apparatus, an epidermal derivative that bears many similarities to
the hair follicle (Dawber and Baran, 1984; Baden and Kvedar, 1993).
We report that PAI-2 is consistently expressed in the more differentiated
keratinocyte populations of each of these tissues, consistent with a role
in protecting cells from premature cell death.
MATERIALS AND METHODS
Anti-PAI-2 immunohistochemistry Anti-mouse PAI-2 anti-serum was
prepared by injection of a rabbit with mouse PAI-2:GST fusion protein that
had been purified from inclusion bodies by 8 M urea extraction and glutathione-
Sepharose chromatography. The anti-serum was absorbed with sham transfected
bacterial lysates to remove any cross-reactivity with either bacterial or GST
antigens. The IgG fraction was isolated using a Protein A column. Western
blots showed that this anti-serum recognized recombinant mouse PAI-2 as well
as a single band in mouse epidermal extracts at 43 kDa, the size of mouse
PAI-2 (Wohlwend et al, 1987).
For staining, skin from the nape of the neck and hind feet was removed
from mice of the indicated ages, fixed overnight in 4% paraformaldehyde in
phosphate buffered saline (PBS) pH 7.0, washed and incubated overnight in
80% ethanol, and then processed for paraffin embedding and sectioning (6 µm).
After dehydration, sections were fixed again in 4% paraformaldehyde in PBS
pH 7.0; blocked for 1 h at room temperature with 10% goat serum in PBS;
and incubated overnight at 4°C with rabbit anti-mouse PAI-2 IgG or normal
rabbit IgG as a control (5 µg per ml in PBS containing 10% goat serum). After
washing in PBS, slides were incubated with biotinylated goat anti-rabbit IgG
(Vectastain Laboratories, Burlingame, CA) for 1 h at room temperature, washed,
incubated with avidin-biotin-peroxidase reagent (Vectastain) for 45 min at room
temperature, and washed again. Staining was then visualized by reaction
with diaminobenzidine for 10–15 min at room temperature, according to
manufacturer’s directions (Sigma, St Louis, MO). Slides were washed a final
time in PBS, stained with hematoxylin (Gill #1), dehydrated, mounted with
permount and coverslipped. Mice of several strains (C57Bl/6, C3H/129 hybrids,
Sencar) were utilized and no differences were noted among strains.
PAI-2 in situ hybridization A 930 bp Pst1/PvuII fragment of mouse PAI-
2 (Belin et al, 1989) was subcloned into pBluescript SK6 at EcoR1/HindIII;
digestion with HindIII and transcription with T3 were utilized for anti-sense
probes, and digestion with SmaI and transcription with T7 were utilized for
sense probes. RNA probes were prepared using 35S-labeled UTP. In situ
hybridization was conducted as described (Keeton et al, 1993; Jensen and
Lavker, 1996) using paraffin sections of skin and nail.
Transmission electron microscopy Skin was fixed and processed for
transmission electron microscopy as described previously (Cotsarelis et al, 1990).
RESULTS
PAI-2 is expressed in the hair follicle The hair follicle comprises at
least seven typesofmorphologically and/orbiochemicallydistinguishable
keratinocytes that spatially organize and coordinately differentiate to
form the outer root sheath, inner root sheath, and hair shaft (Hashimoto
and Shibazaki, 1976; Reynolds and Jahoda, 1993; Kamimura et al, 1997).
Immunohistochemical and in situ hybridization experiments revealed
that PAI-2 was present only in specific subpopulations of cells, dependent
upon the phase of the hair growth cycle. In the adult mouse, the vast
majority of hair follicles at any given time are in the telogen (i.e., resting)
phase, where the hair shaft is no longer growing, but must be retained in
the follicle. During telogen, PAI-2 antigen and mRNA were found
exclusively in a single layer of nucleated, outer root sheath keratinocytes
that were adjacent to and organized around the hair shaft (Fig 1). In
cross-section, the PAI-2-stained cells appeared as a prominent ring
encircling the hair shaft (Fig 1, inset). These cells were consistently at
least one cell layer removed from the basal cell population, which is
contiguous with the basal layer of epidermis and constitutes the
proliferative layer. Within these outer root sheath cells the PAI-2 staining
patternwas predominantly cytoplasmic.ThePAI-2-stainedkeratinocytes
displayed ultrastructural features that were typical of viable cells
(Fig 2a, b). They possessed a large nucleus with prominent chromatin;
no evidence of nuclear fragmentation, clumped chromatin, or nuclear
membrane blebbing was apparent. The cytoplasm was filled with ribo-
somes and copious bundles of keratin filaments. Lysosomes, autophagic
vacuoles, and lipid droplets, features associated with dying cells, were not
present. These PAI-2-staining cells interlocked with the remnants of the
inner root sheath, along a highly interdigitating interface, suggesting that
they were involved in anchoring the hair shaft to the base of the follicular
epithelium. Even after the follicle re-entered the growth phase, leading
to initiation of a new hair shaft, the cells surrounding the old hair shaft
(club hair) retained PAI-2 (Fig 3a).
In the newly forming anagen hair follicle, whether during the first
or subsequent hair growth cycles, PAI-2 was initially very difficult to
detect; however, later in anagen, PAI-2 staining was detectable in a
single line of cells beginning near or above the critical line of Auber
(marking the widest diameter of the follicle; Auber, 1950–1951) and
extending upward toward the mid-region of the follicle (Fig 3b). The
region below this line is of significance because it is the site of the
majority of proliferative activity in the follicle, and little or no PAI-2
mRNA or protein was observed in the matrix keratinocytes of this
region. In the mid-region of the follicle (Fig 3c), it became apparent
that PAI-2 was present exclusively in a single layer of very flat cells,
which abuts the inner root sheath. This layer has previously been
described as the ‘‘companion’’ layer (Orwin, 1971) or the innermost
layer of the outer root sheath (Ito et al, 1986; Ito, 1988). Closer to
the skin surface, near the infundibulum (Fig 3d), where the inner root
sheath is totally disintegrating, these innermost outer root sheath cells
assume an irregular shape with a serrated surface facing the hair shaft.
Interestingly, these cells initially retained their nuclei, consistent with
earlier findings (Ito, 1988) that, in the mouse, these cells do not
keratinize until a very late stage when the inner root sheath has
completely degenerated. These irregularly shaped cells also initially
retained strong staining for PAI-2 (Fig 3d), but then lost detectable
PAI-2 when they moved slightly farther up the follicle and finally
began to keratinize. Hence the innermost cells of the outer root sheath
contained PAI-2 along almost the entire length of the follicle, until they
underwent terminal differentiation and death near the infundibulum.
PAI-2 was also expressed during anagen by a second subset of cells,
the medulla cells, which form a vertical column in the center of the
hair shaft (Fig 3c–h). The medulla cells in the keratogenous zone, just
above the bulb, are the least differentiated, and upward vertical
movement is coordinate with increasing differentiation. Only a subpop-
ulation of medulla cells, i.e., those in the mid-region of the follicle,
contained PAI-2 mRNA (Fig 3f, g); intense staining for PAI-2 antigen
was also detected in this region (Fig 3h). Newly forming medulla cells
in and just above the keratogenous zone contained neither PAI-2
antigen nor mRNA (Fig 3f, g). Furthermore, the highly differentiated
medulla cells approaching the skin surface expressed no PAI-2 mRNA
(Fig 3f), although weak immunostaining for PAI-2 was often observed
(Fig 3h), suggesting retention of this protein. The extremely intense
and highly localized signal for PAI-2 mRNA, which is mirrored by
the antigen, indicates an acute induction of synthesis of the inhibitor
during a very specific stage in medulla cell differentiation. In contrast,
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Figure 1. PAI-2 is expressed in the outer
root sheath of telogen follicles. Skin from
mice in the telogen phase of the hair growth
cycle was processed for immunostaining with
rabbit antibody against mouse PAI-2, using
avidin-biotin-peroxidase and diaminobenzidine
detection (a), or for in situ hybridization with
35S-labeled anti-sense (b) or sense (c) probes to
PAI-2. Longitudinal sections of telogen follicles
are shown in (a)–(c); the insets show cross-
sections. PAI-2 mRNA and antigen are detected
in a single layer of cells that surrounds the hair
shaft (H). SG, sebaceous gland; FP, follicular
papilla; E, epidermis. Scale bar, 20 µm.
Figure 2. Outer root sheath cells during the telogen phase of the hair
growth cycle show no evidence of degeneration. (a) Ultrastructure of the
lowermost portion of a follicle during the telogen phase of the hair growth
cycle showing the relationship between the outer root sheath cells (ORS) and
the hair shaft (H). Arrows point to those cells immediately adjacent to the hair
shaft that, as shown in Fig 1, express PAI-2. The area within the rectangle is
shown at a higher magnification in (b). FP, follicular papilla. Scale bar, 5 µm.
(b) Outer root sheath cells (ORS) immediately adjacent to the fully cornified
inner root sheath (IRS) appear viable as evidenced by their intact nuclei
and well organized cytoplasm filled with abundant ribosomes. The highly
interdigitating boundary (arrowheads) between the ORS cells and the IRS
suggests that these two follicular regions form a tight complex. The hair shaft
cuticle (Cu) also interlocks with the IRS anchoring the telogen hair. Scale
bar, 1 µm.
the PAI-2 mRNA in the outer root sheath during telogen appears to
be constitutively present (Fig 1b), albeit at a lower level.
During catagen (Fig 3i, j ), there is very rapid degeneration of the
bulb and lower end of the follicle, which shrinks to approximately
one-third its original size (Chase, 1954; Dry, 1962). PAI-2 was strongly
expressed in catagen follicles, in a population of epithelial cells just
beneath the hair shaft that represent the permanent portion of the
follicle and most likely secure the hair shaft. Little or no PAI-2 was
detected in the thin, wispy, strands of cells within the connective tissue
sheath that comprised the lower part of the catagen follicle and were
destined to die.
PAI-2 is expressed in the nail structure Like the hair follicle, the
nail apparatus is comprised of several epithelial cell types, each of
which follows a unique differentiation pathway (Dawber and Baran,
1984; Baden and Kvedar, 1993) and several of which stained for PAI-
2 (Fig 4). In the matrix cells, whose terminal differentiation product
is the nail plate, PAI-2 was detected in all layers except for the
proliferative basal layer (Fig 4). Most intriguingly, the staining for
PAI-2 gradually became fainter and was then lost altogether just as the
cells lost their nuclei and underwent the final stages of terminal
differentiation to generate the fully keratinized nail. PAI-2 was also
strongly detected in the epithelial cells that formed the nail bed (i.e.,
that epithelium that lies beneath the nail plate and anchors it). Similar
to the matrix epithelium, only the differentiated cells, and not the
basal cells, of the nail bed stained for PAI-2.
DISCUSSION
Localization of PAI-2 to specific subsets of cells within the diverse
epithelial cell types that comprise the hair follicle and the nail apparatus
has functional implications relating to the hypothesis that this inhibitor
endows cells with resistance to terminal differentiation, a highly
specialized form of programmed cell death (McCall and Cohen, 1991;
Polakowska and Haake, 1994). In no case is PAI-2 observed in the
proliferative precursor cells that give rise to any components or
structures in the hair follicle or nail apparatus. Specifically, PAI-2 is
not expressed in the highly proliferative matrix keratinocytes of the
follicular bulb that give rise to the inner root sheath and the hair fiber,
nor in the basal cells of the outer root sheath. Likewise the basal,
proliferative populations of the nail matrix and nail bed do not express
PAI-2; however, in many cases, the more differentiated progeny of
these precursor populations do express PAI-2. These observations are
consistent with our previous finding that PAI-2 is preferentially
expressed by the suprabasal layers of human epidermis (Lyons-Giordano
et al, 1994), and suggest that, in many of the epithelial cell types that
comprise the epidermal appendages, PAI-2 can be considered as a
differentiation marker.
In the outer root sheath cells of the hair follicle, the specifics of
differentiation vary with the hair growth cycle, as does the expression
of PAI-2. In anagen, the outer root sheath appears more complex than
in telogen, consisting of a basal layer, a variable number of intermediate
layers depending on position in the follicle, and a single layer of
innermost cells. This innermost layer is the only subpopulation of the
outer root sheath that expresses PAI-2. The cells of the innermost layer
exhibit distinct ultrastructural features and a distinct keratin pattern
compared with the outer layers of the outer root sheath or with the
inner root sheath (Orwin, 1971; Ito et al, 1986; Ito, 1988; Rothnagel
and Roop, 1995). These cells can be further distinguished from the
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Figure 3. PAI-2 is expressed in anagen and
catagen follicles. Immunostaining (a–d; h–j)
or in situ hybridization (e–g) for PAI-2 was
carried out, as in Fig 1, on skin taken from
mice in the anagen (a–h) or catagen (i, j) phases
of the hair growth cycle. (a) Follicles at an early
stage of the second anagen, showing PAI-2
immunostaining in the outer root sheath of the
club hair (H). (b) The lower portion of an
anagen follicle, showing PAI-2 immunostaining
(arrows) beginning around the critical line of
Auber (marked with a black line) in the bulb,
and extending upwards. Skin was taken from a
black-haired mouse, hence the heavy
concentration of melanin in the center of the
follicle. (c) Longitudinal section of the mid-
portion of an anagen follicle, showing PAI-2
immunostaining in a single line of flat cells
(arrows), which is the innermost layer of the
outer root sheath. Staining is also present in the
medulla cells (M), alternating with the black
pigment. (d) Section of the upper portion of an
anagen follicle, where the inner root sheath is
disintegrating and the innermost cells of the
outer root sheath assume an irregular shape.
Note PAI-2 immunostaining in the lower
irregularly shaped cells (arrow), but not in the
adjacent upper ones. (e) Sense control for in
situ hybridization shown in (f). (f) PAI-2 in situ
hybridization of skin from an 18 d old white-
haired mouse, late in the first anagen phase.
Strong signal for PAI-2 mRNA is found in a
population of medulla keratinocytes in the mid-
portion of the follicles (arrow). Signal is not
detected in the less mature medulla cells in and
just above the keratogenous zone (*), nor in
the keratinizing medulla cells closer to the skin
surface (arrowhead). The boxed area is shown
at a higher magnification in (g). (h) PAI-2
immunostaining of an anagen follicle from a
white-haired mouse, showing strong signal in
the medulla cells in the mid-portion of the
follicle, similar to the localization of PAI-2
mRNA. (i) PAI-2 immunostaining of a catagen
follicle, showing strong staining in a group of
cells (arrow) in the permanent portion of the
follicle, beneath the retracting hair shaft. (j) A
catagen follicle stained with normal rabbit IgG
as a control for (i). Scale bars, (a–d, g–j) 40 µm;
(e, f) 80 µm.
Figure 4. Differentiated cells of the nail
apparatus express PAI-2. The nail region of
the hind foot of a 3 wk old mouse was stained
with anti-PAI-2 antibody. Note staining in the
differentiating cells of the nail matrix (M),
which gradually disappears as the cells lose their
nuclei and keratinize to form the nail plate
(NP). Note staining also in the uppermost,
differentiated layer of the nail bed (NB).
Staining is not detected in the basal cells
(arrowheads) of either epithelium. Scale bar,
66 µm. The boxed area is shown at a higher
magnification in the inset. Scale bar, 40 µm.
VOL. 110, NO. 6 JUNE 1998 PAI-2 IN HAIR AND NAIL 921
inner root sheath in that they lack trichohyalin (Rothnagel and Roop,
1995). Our findings are consistent with the idea that these cells are
unique. At present there are two possibilities regarding the origin of
the cells of the innermost layer of the outer root sheath: (i) they may
be the terminally differentiated form of the outer root sheath cells,
originating from the basal layer of epidermis; or (ii) they may represent
a distinct lineage from the other cells of the outer root sheath and
originate from the matrix keratinocytes of the follicular bulb (Orwin,
1971; Reynolds and Jahoda, 1993). Although we cannot distinguish
between these two possibilities, our demonstration of a single line of
PAI-2-positive cells emanating from the bulb and extending vertically
nearly to the infundibulum favors the second possibility.
Regardless of the origin of the innermost cells of the outer root
sheath, it is curious that this population is the only one in the inner
or outer root sheath to express PAI-2. Based on a correlation between
PAI-2 expression and the relative rates at which the inner and outer
root sheath cells keratinize, we suggest that this may be consistent with
a protective role for PAI-2 in prevention of premature keratinization
and death. Specifically, Henle’s layer, in the inner root sheath, cornifies
early in anagen, prior to any other layer (Hashimoto and Shibazaki,
1976); the other layers of the inner root sheath quickly follow. Another
characteristic of Henle’s layer is that it is very tightly bound to the
innermost layer of the outer root sheath (Reynolds and Jahoda, 1993),
which contains PAI-2. Given these observations, we speculate that
Henle’s layer and the rest of the inner root sheath cells do not express
PAI-2 because they keratinize quickly. In contrast, the innermost cells
of the outer root sheath, which keratinize very late (Ito, 1988) and
thus have a much longer postmitotic maturation time, require PAI-2
for protection from premature death.
In comparison with the outer root sheath of the anagen follicle, the
telogen outer root sheath is less complex. In telogen, PAI-2 becomes
strictly limited to a subset of relatively differentiated epithelial cells that
surround the hair shaft, interdigitating with the fully cornified remnants
of the inner root sheath. Although the PAI-2-positive cells in the
telogen follicle are postmitotic, they remain viable and metabolically
active, as evidenced by our ultrastructural and in situ hybridization
analyses, and do not undergo terminal keratinization and death. As
during anagen, expression of PAI-2 during telogen may confer protec-
tion to these cells from programmed cell death. It is likely that their
continued viability is necessary to ensure that the hair shaft remains
securely embedded in the follicle. In contrast to the human, murine
hairs are essential for physical protection and thermo-regulation,
and thus their retention is crucial to survival. PAI-2 appears to be
constitutively synthesized by the more differentiated outer root sheath
cells during telogen, as not only antigen but also mRNA for PAI-2 is
detectable throughout the entire resting phase. These data imply a
turnover and hence utilization of PAI-2.
Even in the brief degenerative stage between anagen and telogen,
the follicle expresses PAI-2 in a manner consistent with our hypothesis
of a protective role for this inhibitor against programmed cell death.
The molecules responsible for initiation and regulation of programmed
cell death during catagen have not been defined, although there is
evidence that cytokines, including TNF-β and TGF-β, may play a
role (Seiberg et al, 1995). In the environment of large-scale cell
destruction that characterizes catagen, it is essential that the relatively
small permanent population of cells in the follicle do not succumb to
the death signals. We hypothesize that PAI-2 expression by a small
group of cells in the catagen follicle protects them from the regulatory
molecules that signal the demise of most of their neighboring cells.
This hypothesis is consistent with the suggestion that TNF is a mediator
of programmed cell death during catagen, as PAI-2 has been shown
to protect cells lines from programmed cell death mediated by this
cytokine (Kumar and Baglioni, 1991).
At present it is not possible to determine if the various follicular cell
populations that we have identified as producing PAI-2 (i.e., the
innermost cells of the outer root sheath during anagen, the epithelial
cells at the base of permanent hair shaft during catagen, and the inner
ring of epithelial cells during telogen) are distinctly derived populations,
or alternatively are cycle-dependent manifestations of a common
precursor. Appropriate markers do not exist to determine the fate of
the innermost cells of the outer root sheath when anagen ends and
catagen/telogen begins.
Although the hair and the nail serve different functions, many
structural analogies can be drawn between these two tissues, with the
nail apparatus similar in many ways to a hair follicle cut in half
longitudinally. It has thus been suggested that the outer root sheath is
analogous to the nail bed, with each anchoring a fully keratinized,
hardened structure (i.e., the hair fiber and the nail plate, respectively)
(Dawber and Baran, 1984; Baden and Kvedar, 1993). Interestingly,
both the outer root sheath and the nail bed express PAI-2, specifically
in the more differentiated cells of each, closest to the hair fiber and
nail plate. A second structural analogy can be drawn between the hair
fiber and the nail plate, which again corresponds to a common
expression of PAI-2. The nail matrix keratinocytes, which form the
nail plate, and the medulla cells, which form the central core of the
hair shaft, both express PAI-2 during particular stages of differentiation.
The nail plate is also analogous to the stratum corneum, as both
terminal differentiation products show complete enucleation as well as
autolysis of all cell organelles. Consistent with this analogy, PAI-2 is
expressed in the granular layer of epidermis from human skin (Lyons-
Giordano et al, 1994) and mouse footpad (Risse et al, unpublished
observations). In all of these cases of terminal differentiation (i.e., nail
matrix to nail plate, medulla cells to a component of the hair fiber,
and basal keratinocytes to stratum corneum), numerous specific,
complex differentiation products must be elaborated (Rogers and
Harding, 1976; Jones and Steinert, 1996). Such terminal differentiation
requires a long postmitotic maturation period, and too rapid a progres-
sion to cell death may not allow sufficient time to generate all the
crucial products. We suggest that PAI-2 in each case may protect the
postmitotic cells from entering prematurely into the final stages of
terminal differentiation and death, thereby insuring a completely formed
end product.
As discussed above, there appears to be a continuous utilization of
PAI-2 by the differentiated cells of the outer root sheath of the hair
follicle, as evidenced by the constitutive presence of both its mRNA
and its protein throughout telogen. This raises the interesting question
of what is the target proteinase for PAI-2? Classically, uPA has been
considered as the physiologic target for PAI-2 (Andreasen et al, 1990,
1997), although there are several problems with this idea with respect
to the epithelia of the hair and nail. First, we have not been able to
detect uPA in the hair shaft or follicular epithelium, either by in situ
hybridization or by immunostaining (Jensen and Lavker, 1996). uPA
was not present during follicular neogenesis or during any of the phases
of the naturally occurring or experimentally induced hair growth cycle.
Secondly, uPA is secreted (Andreasen et al, 1997), and thus its inhibitor
should also be secreted. PAI-2 is an unusual serine proteinase inhibitor
in that, at least in vitro, it is largely accumulated within the cytoplasm
of numerous cell types, including the keratinocyte (Jensen et al, 1995;
Kruithof et al, 1995). Although we cannot determine from our present
data the relative proportion of intracellular to secreted PAI-2, the
staining patterns and intensity are consistent with a substantial amount
of cytoplasmic PAI-2 in the follicular and nail epithelia. Finally, there
is to date no evidence that plasminogen activator activity may mediate
programmed cell death. On the contrary, Dickinson et al (1995) have
provided evidence that uPA inhibition is not the mechanism by which
transfected PAI-2 protects HeLa cells from programmed cell death.
Hence, we believe that PAI-2 in the hair and nail may have a
cytoprotective, cytoplasmic role, which involves inhibition of pro-
teinase(s) other than plasminogen activators.
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